Skip to content

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03718364
Acronym
SWISS-AF-PVI)
Enrollment
3000
Registered
2018-10-24
Start date
2010-07-01
Completion date
2035-12-31
Last updated
2025-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-based Ablation of Atrial Fibrillation

Keywords

atrial fibrillation, pulmonary vein isolation

Brief summary

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Interventions

PROCEDUREcatheter-based ablation of atrial fibrillation (pulmonary vein isolation)

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Exclusion criteria

* Patients not able or willing to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)before catheter-based ablation of atrial fibrillation and 3, 6 and 12 months after catheter-based ablation of atrial fibrillationchanges in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Secondary

MeasureTime frameDescription
morphologic changes of left cardiac atriumbefore catheter-based ablation of atrial fibrillation (pulmonary vein isolation)echocardiography of left cardiac atrium
changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)12 months after catheter-based ablation of atrial fibrillation and then at intervals of one year until 2035changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Other

MeasureTime frameDescription
determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillationBlood samples gained during catheter-based ablation of atrial fibrillation (pulmonary vein isolation)Blood samples (biobanking) for determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation). Decisions about future analyses to be performed from stored samples will be based exclusively on scientific reasons.

Countries

Switzerland

Contacts

Primary ContactMichael Kuehne, MD
michael.kuehne@usb.ch+41 61 328 74 71
Backup ContactGian Voellmin, MSc
gian.voellmin@usb.ch+41 61 556 52 96

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 4, 2026